All Journals > Infection Control and Hospital Epidemiology > November 2006 > Comparative Cost of Selective Screening for MRSA

Article Tools

Search for Related Articles

  • By Author
  • Search In

Highlighted Article

NHSN Annual Update:
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections

Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007

Antimicrobial-resistant pathogens that cause healthcare-associated infections (HAIs) pose an ongoing and increasing challenge to hospitals, both in the clinical treatment of patients and in the prevention of the cross-transmission of these problematic pathogens.  Describing the magnitude of the problem with respect to these antimicrobial-resistant pathogens is challenging, because the levels of antimicrobial resistance vary for different types of healthcare facilities and for different geographic areas, and some resistance phenotypes are difficult for laboratories to detect. However, the findings from such attempts may help the infection control and public health communities target problems and utilize resources more efficiently.

In the News

Featured in The Times
"Ireland 'losing war' on superbug" February 15, 2009
Challenges of Implementing National Guidelines for the Control and Prevention of Methicillin‐Resistant Staphylococcus aureus Colonization or Infection in Acute Care Hospitals in the Republic of Ireland
Fidelma Fitzpatrick, MD; Fiona Roche, PhD; Robert Cunney, MB; Hilary Humphreys, MD; Strategy for the Control of Antimicrobial Resistance in Ireland Infection Control Subcommittee
The research, published in Infection Control and Hospital Epidemiology, found one third of hospitals did not have a written policy on antibiotic use, and only 35% had an antibiotic stewardship programme.

November 2006

Volume 27, Number 11
Infect Control Hosp Epidemiol 2006;27:1264–1266
0899-823X/2006/2711-0023$15.00
DOI: 10.1086/507968
Concise Communication

Comparative Cost of Selective Screening To Prevent Transmission of Methicillin‐Resistant Staphylococcus aureus (MRSA), Compared With the Attributable Costs of MRSA Infection

Laura Gavaldà, MD;

Cristina Masuet, MD;

Juan Beltran, MD;

Maria Garcia, MD, PhD;

Delia Garcia, MD;

Josep M. Sirvent, MD, PhD;

Josep M. Ramon, MD, PhD

From the Hospital de Girona Dr. Josep Trueta, Girona (L.G., C.M., J.B., M.G., D.G., J.M.R., J.M.S.), and the Hospital Universitari de Bellvitge, l’Hospitalet de Llobregat, Barcelona (L.G., C.M., J.B., J.M.R.), Spain.

The annual cost of a screening program to detect methicillin‐resistant Staphylococcus aureus (MRSA) in a teaching hospital in Spain was €10,261. The average cost per MRSA infection was €2,730; therefore, the cost of the program would be covered if it only prevented 4 infections per year (11% of the total number of MRSA infections at our hospital).

Received June 28, 2004; accepted March 31, 2006; electronically published September 28, 2006.

Address reprint requests to Laura Gavaldà, MD, Department of Preventive Medicine, Hospital Universitari de Bellvitge, Feixa Llarga, s/n. 08907 L’Hospitalet de Llobregat, Barcelona, Spain ().

Cited by

Eric D. Schultz, DO, MPH; David T. Tanaka, MD; Ronald N. Goldberg, MD; Daniel K. Benjamin, Jr., MD, MPH, PhD; P. Brian Smith, MD, MHS. (2009) Effect of Methicillin‐Resistant Staphylococcus aureus Colonization in the Neonatal Intensive Care Unit on Total Hospital Cost •. Infection Control and Hospital Epidemiology 30:4, 383-385
Online publication date: 1-Apr-2009.
Daniel P. McQuillen, Russell M. Petrak, Ronald B. Wasserman, Ronald G. Nahass, Jason A. Scull, and Lawrence P. Martinelli. (2008) The Value of Infectious Diseases Specialists: Non–Patient Care Activities. Clinical Infectious Diseases 47:8, 1051-1063
Online publication date: 15-Oct-2008.
A. Manzur, L. Gavalda, E. Ruiz de Gopegui, D. Mariscal, M. A. Dominguez, J. L. Perez, F. Segura, M. Pujol, . (2008) Prevalence of methicillin-resistant Staphylococcus aureus and factors associated with colonization among residents in community long-term-care facilities in Spain. Clinical Microbiology and Infection 14:9, 867-872
Online publication date: 1-Oct-2008.
CrossRef
By Cheng-Chuan Hsu, MS; Yusen E. Lin, PhD, MBA; Yao-Shen Chen, MD; Yung-Ching Liu, MD; Robert R. Muder, MD. (2008) Validation Study of Artificial Neural Network Models for Prediction of Methicillin-Resistant Staphylococcus aureus Carriage. Infection Control and Hospital Epidemiology 29:7, 607-614
Online publication date: 1-Jul-2008.
Katharine L. McGinigle, Margaret L. Gourlay, and Ian B. Buchanan. (2008) The Use of Active Surveillance Cultures in Adult Intensive Care Units to Reduce Methicillin‐Resistant Staphylococcus aureus–Related Morbidity, Mortality, and Costs: A Systematic Review. Clinical Infectious Diseases 46:11, 1717-1725
Online publication date: 1-Jun-2008.
D. Ornskov, B. Kolmos, P. Bendix Horn, J. Nederby Nielsen, I. Brandslund, P. Schouenborg. (2008) Screening for methicillin-resistant Staphylococcus aureus in clinical swabs using a high-throughput real-time PCR-based method. Clinical Microbiology and Infection 14:1, 22-28
Online publication date: 1-Feb-2008.
CrossRef
Erin O'Fallon, Jane Harper, Shelly Shaw, Ruth Lynfield. (2007) Antibiotic and Infection Tracking in Minnesota Long-Term Care Facilities. Journal of the American Geriatrics Society 55:8, 1243-1247
Online publication date: 1-Sep-2007.
CrossRef
Close Popup